-
JSH-23: A Practical NF-κB Inhibitor Workflow
2026-09-08
JSH-23 helps separate NF-κB p65 nuclear transcriptional activity from upstream IκB degradation, making it useful for mechanistic inflammation research and cytokine studies. This workflow connects macrophage assays with evidence from a pseudorabies virus model while clearly distinguishing validated applications from translational experiments.
-
InstaBlue Protein Stain Solution for Antibody Studies
2026-09-07
InstaBlue Protein Stain Solution accelerates antibody-development workflows by visualizing protein bands in about 5 minutes without fixation, washing, or destaining. Its low-background, methanol- and acetic acid-free formulation supports gel-based quality control, band excision, and mass spectrometry-oriented analysis.
-
Honokiol Workflows for Cancer Drug Response Assays
2026-09-05
Honokiol can be deployed as an NF-κB pathway inhibitor, reactive oxygen species scavenger, and cancer research probe when viability, cell death, and pathway readouts are separated. This workflow translates those activities into practical dose-response, inflammation, oxidative-stress, and antiangiogenic assay designs.
-
Intravesical p21 mRNA-LNP for Bladder Cancer
2026-09-05
This 2026 FASEB Journal study develops lipid nanoparticles carrying chemically modified p21 mRNA for localized bladder cancer treatment. The work links intravesical delivery with tumor-suppressor restoration, cell-cycle inhibition, DNA-damage signaling, and limited systemic exposure, while also defining important preclinical limitations.
-
BAPTA for Calcium Signaling and Apoptosis
2026-09-04
Use BAPTA as a mechanistic calcium chelator to test whether intracellular Ca2+ elevation is a driver of toxicant-induced apoptosis. This workflow translates an IP3R/Ca2+/STAT3 study into practical controls for intestinal cell models, calcium signaling modulation, and broader cell signaling studies.
-
Fluorouracil Workflows for Solid-Tumor Research
2026-09-04
Build more informative Fluorouracil experiments by pairing thymidylate synthase engagement with viability, replication-stress, and pathway-level readouts. This workflow uses validated colon-tumor benchmarks while extending assay design to cancer-stem-cell biology, including TAK1–YAP regulation in gastric models.
-
ABT-199 Workflow for Mitochondrial Apoptosis
2026-09-03
ABT-199 (Venetoclax) provides a selective way to test whether BCL-2 dependence is driving survival in lymphoma and leukemia models. This practical guide connects dose–response testing, apoptosis readouts, BH3 profiling, and resistance analysis while clarifying how findings from diffuse mesothelioma research should—and should not—be translated.
-
Exercise Capacity Falls Before Muscle Dysfunction
2026-09-03
Zhang et al. show that exercise intolerance develops before measurable intrinsic skeletal muscle dysfunction in experimental pulmonary hypertension. By comparing rat strains with different disease severity, the study separates cardiopulmonary limitations from later muscle atrophy and provides a useful framework for interpreting VO2 max changes in pulmonary hypertension models.
-
MK-0812 Workflow for CCR2 Studies in MASH
2026-09-02
Use MK-0812 to separate CCR2-dependent monocyte recruitment from gut–liver mechanisms in MASH models. This workflow combines quantitative ex vivo pharmacology, flow cytometry, and tissue-level validation to turn a monocyte trafficking inhibitor into a mechanistic research tool.
-
A40926 Workflows for MIC and Dalbavancin Research
2026-09-02
A40926 combines a well-defined cell-wall mechanism with useful activity against Gram-positive pathogens and Neisseria gonorrhoeae. This practical guide covers MIC testing, structure–activity experiments, resistant-pathogen studies, troubleshooting, and translation toward dalbavancin research.
-
Nigericin Sodium Salt: Practical Assay Guide
2026-09-01
Nigericin sodium salt is a potassium ionophore for experimentally altering K+/H+ exchange, ion gradients, and cytoplasmic pH in membrane and cell-based assays. It is suited to controlled research workflows, including platelet aggregation and lead (Pb2+) ion transport studies, but its poor water and DMSO solubility and research-only status limit how it can be used.
-
AI-10-49 Workflows for CBFβ-SMMHC Research
2026-09-01
AI-10-49 enables mechanism-led acute myeloid leukemia research by separating direct CBFβ-SMMHC–RUNX1 target engagement from downstream effects on chromatin, MYCN, eIF4G1, and cell survival. This guide presents practical dosing, ChIP, viability, and in vivo workflow strategies, with troubleshooting guidance for reproducible inv(16) leukemia studies.
-
A40926: From Cell-Wall Mechanism to Translation
2026-08-31
A40926 is more than a natural glycopeptide antibiotic: it is a mechanistically defined dalbavancin precursor, a benchmark for Gram-positive bacterial infection research, and a platform for connecting pathway regulation with translational assay design. This article examines its cell-wall target, pathogen-specific activity, biosynthetic control, experimental parameters, competitive context, and strategic value for MRSA research and Neisseria gonorrhoeae inhibition studies.
-
HyperScribe Co-transcription mRNA Synthesis Kit Plus
2026-08-30
Build translationally competent, ARCA-capped mRNA with a defined template-encoded poly(A) tail for in vitro translation, RNA vaccine development, and functional RNA studies. This workflow connects careful template design and RNA quality control with the antigen-engineering logic used in a recent GPC3-HSP70 nanovaccine study.
-
Mitochondrial Calcium Signaling Represses Ferroptosis
2026-08-29
The reference study links mitochondrial calcium uptake through MCU to acetyl-CoA-dependent GPX4 acetylation and sustained suppression of ferroptosis. Genetic, biochemical, structural, and tumor-model evidence suggests that this pathway connects mitochondrial metabolism with lipid peroxide detoxification and cancer-cell survival.